EPO gears up to hear EpiPen patent opposition

27-02-2018

EPO gears up to hear EpiPen patent opposition

Sjo / iStockphoto.com

The European Patent Office (EPO) will hear an opposition against a patent covering Mylan’s EpiPen (epinephrine) at the end of March.


EpiPen, patent opposition, Mylan, ALK-Abello, Meridian Medical Technologies, EPO, Tim Powell, Potter Clarkson, Pfizer,

LSIPR